In an observational study, individuals that have T2DM, GLP-1RA therapy, Liraglutide, reduced pro-inflammatory cytokines (e.g., TNF-, interleukin-1 beta (IL-1), IL-6) in PBMCs, and increased serum adipokine, adiponectin, and macrophage activation markers (sCD163) [95]
Understanding all available options ensures that you can make a well-rounded decision that fits your unique situation.
Comparison Two body-composition combos, different mechanisms
124,125,126 The design concept of these multi-agonists is to simultaneously regulate multiple key metabolic pathways to achieve more effective control over blood sugar, body weight, and overall metabolic health
Early animal studies indicated potential benefits for osteoarthritis
Vitamin B6: Facilitates the transmission of nervous impulses